151 related articles for article (PubMed ID: 2357426)
1. Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures.
Chenu C; Valentin-Opran A; Chavassieux P; Saez S; Meunier PJ; Delmas PD
Bone; 1990; 11(2):81-6. PubMed ID: 2357426
[TBL] [Abstract][Full Text] [Related]
2. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
3. Effect of 17 beta-estradiol on the human osteosarcoma cell line MG-63.
Lajeunesse D
Bone Miner; 1994 Jan; 24(1):1-16. PubMed ID: 8186730
[TBL] [Abstract][Full Text] [Related]
4. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of synthetic insulin-like growth factor I/somatomedin C and 1,25-dihydroxyvitamin D3 on regulation of function in clonal osteoblastic cells.
Kurose H; Seino Y; Yamaoka K; Tanaka H; Shima M; Yabuuchi H
Bone Miner; 1989 Mar; 5(3):335-45. PubMed ID: 2720200
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA
Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089
[TBL] [Abstract][Full Text] [Related]
7. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells.
Ingram RT; Bonde SK; Riggs BL; Fitzpatrick LA
Differentiation; 1994 Jan; 55(2):153-63. PubMed ID: 8143932
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1,25-dihydroxyvitamin D3.
Thavarajah M; Evans DB; Kanis JA
Bone; 1993; 14(5):763-7. PubMed ID: 7505605
[TBL] [Abstract][Full Text] [Related]
9. Lead inhibits the basal and stimulated responses of a rat osteoblast-like cell line ROS 17/2.8 to 1 alpha,25-dihydroxyvitamin D3 and IGF-I.
Angle CR; Thomas DJ; Swanson SA
Toxicol Appl Pharmacol; 1990 Apr; 103(2):281-7. PubMed ID: 2330589
[TBL] [Abstract][Full Text] [Related]
10. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
[TBL] [Abstract][Full Text] [Related]
12. Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.
Antoniazzi F; Radetti G; Zamboni G; Gambaro G; Adami S; Tatò L
Bone Miner; 1993 May; 21(2):151-6. PubMed ID: 8358252
[TBL] [Abstract][Full Text] [Related]
13. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
Linkhart TA; Keffer MJ
Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GJ; Buurman CJ; Staal A; Bos MP; Pols HA
J Biol Chem; 1992 Jun; 267(18):12562-9. PubMed ID: 1320001
[TBL] [Abstract][Full Text] [Related]
16. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro.
Kassem M; Blum W; Ristelli J; Mosekilde L; Eriksen EF
Calcif Tissue Int; 1993 Mar; 52(3):222-6. PubMed ID: 7683248
[TBL] [Abstract][Full Text] [Related]
18. 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin.
Siggelkow H; Schulz H; Kaesler S; Benzler K; Atkinson MJ; Hüfner M
Calcif Tissue Int; 1999 May; 64(5):414-21. PubMed ID: 10203418
[TBL] [Abstract][Full Text] [Related]
19. Local action of exogenous growth hormone and insulin-like growth factor-I on dihydroxyvitamin D production in LLC-PK1 cells.
Wei S; Tanaka H; Seino Y
Eur J Endocrinol; 1998 Oct; 139(4):454-60. PubMed ID: 9820625
[TBL] [Abstract][Full Text] [Related]
20. Localization of 1,25-(OH)2D3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture.
Boyan BD; Schwartz Z; Bonewald LF; Swain LD
J Biol Chem; 1989 Jul; 264(20):11879-86. PubMed ID: 2545688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
